Evidence map›Paper›PMID 34945223›Full record

ArticleJournal of clinical medicine2021

Evaluation of the Use of Antibiofilmogram Technology in the Clinical Evolution of Foot Ulcers Infected by

Albert Sotto, Frédéric Laurent, Sophie Schuldiner, Julien Vouillarmet, Stéphane Corvec, Pascale Bemer, David Boutoille, Catherine Dunyach-Rémy, Jean-Philippe Lavigne

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02378493 (Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02378493 nacompletednot on this map

Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections

TypeinterventionalSponsorCentre Hospitalier Universitaire de NīmesRan2015 to 2019Enrolled33ConditionsDiabetic Foot, Staphylococcus AureusArmsAntibiofilmogramme
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Antibiofilm Properties of Antiseptic Agents Used onInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Albert SottoVirulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, Service de Maladies Infectieuses et Tropicales, CHU Nîmes, 30908 Nîmes, France.ORCID 0000-0002-6463-9386
Frédéric LaurentCIRI-Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Université Lyon, 69007 Lyon, France.
Sophie SchuldinerVBIC, INSERM U1047, Université de Montpellier, Service des Maladies Métaboliques et Endocriniennes, CHU Nîmes, CEDEX 09, 30029 Nîmes, France.
Julien VouillarmetService d'Endocrinologie, Diabétologie et Nutrition, Hôpital Lyon-Sud, Hospices Civils de Lyon, 69002 Lyon, France.
Stéphane CorvecService de Bactériologie et des Contrôles Microbiologiques, CHU de Nantes, 44093 Nantes, France.ORCID 0000-0003-3176-8111
Pascale BemerDepartment of Microbiology, University Hospital of Nantes, 44093 Nantes, France.ORCID 0000-0001-5892-2946
David BoutoilleDepartment of Infectious Diseases, CIC UIC 1413 INSERM, University Hospital, 44000 Nantes, France.
Catherine Dunyach-RémyVirulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, Service de Microbiologie et Hygiène Hospitalière, CHU Nîmes, 30908 Nîmes, France.ORCID 0000-0001-6884-470X
Jean-Philippe LavigneVirulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, Service de Microbiologie et Hygiène Hospitalière, CHU Nîmes, 30908 Nîmes, France.ORCID 0000-0002-9484-0304
Inserm · FRCentre Hospitalier Universitaire de Nantes · FRHospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infected diabetic foot ulcers (DFUs) represent a serious threat to public health because of their frequency and the severity of their consequences. DFUs are frequently infected by bacteria in biofilms, obstructing antibiotic action. Antibiofilmogram was developed to assess the impact of antibiotics to inhibit biofilm formation. This pilot study aimed to determine the benefits of this technology in predicting antibiotic activity on the outcome of 28 patients with Grade 2 DFUs that were infected by a monomicrobial

Indexed as

Antibiofilmogramantibioticsbiofilmdiabetic foot infectionsStaphylococcus aureuswound healing

Identifiers

PMID34945223
PMCPMC8705769
OpenAlexW4200388156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.